Freder Shen

/Patent Agent
Professional fields
Patent prosecution, Patent invalidation, Administrative litigation, Patent/FTO analysis, Legal opinion
Technical fields
Materials, Chemistry, Semiconductor, Electronics, Photo electronics
Profile
Mr. Shen is an accomplished professional with a robust academic background and extensive experience in intellectual property law. He earned his Bachelor of Engineering degree in Material Science and Engineering in 2005, followed by a Master of Engineering degree in Information Functional Materials in 2008, both from Beijing University of Aeronautics and Astronautics. Throughout his university tenure, Mr. Shen delved deeply into various disciplines including materials, chemistry, electronics/photo electronics, and semiconductors, laying a solid foundation for his subsequent career in patent law. Complementing his academic achievements, Mr. Shen pursued specialized training in patent practice, including patent translation, offered by RWS of the UK, and patent practice training in China. Since joining Kangxin Partners, P.C. in 2008, Mr. Shen has been instrumental in delivering exceptional patent drafting, prosecution, re-examination, invalidation, and administrative litigation services to an esteemed clientele comprising renowned global entities such as SONY, SIEMENS, Hyundai, SAMSUNG, SABIC, Abbott, L'Oreal, OSRAM, BOEING, and Broad Institute. Mr. Shen's expertise spans across diverse industries, with a predominant focus on materials, battery technology, optics, semiconductors, and displays. He has successfully managed a myriad of patent cases for foreign clients, showcasing his prowess in formulating effective patent application strategies tailored to the intricacies of the Chinese intellectual property landscape. Mr. Shen, esteemed as a litigant patent attorney by the All-China Patent Attorneys Association, possesses the qualifications to represent clients in a wide spectrum of legal proceedings. With expertise extending to administrative litigations concerning patent prosecution and invalidation, as well as civil litigations pertaining to patent infringement, Mr. Shen is adept at navigating the intricacies of intellectual property law. His involvement in numerous invalidation and litigation cases underscores his commitment to safeguarding clients' rights within the dynamic legal landscape of China, ensuring their interests are vigorously defended and upheld. Moreover, Mr. Shen is actively engaged in knowledge dissemination and professional development within the realm of patent law. He serves as a distinguished lecturer at Kangxin's Training Center and the Intellectual Property Training Center of China, imparting insights on China's Patent Law and patent practice. Additionally, he holds a position as a lecturer in the Intellectual Property Protection Service Expert Database of the Beijing Patent Attorneys Association, where he delivers lectures on Chinese patent law, patent prosecution practice, and patent infringement litigations to esteemed entities including Fortune Global 500 Enterprises. In recognition of his contributions and leadership within the field, Mr. Shen was appointed as the head of the Chemistry and Biology Division of the Foreign Patent Department in 2014. Furthermore, he obtained his PMP (Project Manager Professional) certification, further enhancing his capabilities in project management. Mr. Shen's influence extends beyond his professional practice. He played a pivotal role in spearheading the "Zhinanzhen (Intellectual Property Compass)" project of the IP Protection Division of CNIPA (China National Intellectual Property Administration), aimed at facilitating Chinese applicants in securing overseas IP protections. Additionally, he led the drafting of crucial documents such as Overview of the Brazilian IP Environment, Overview of the Australian IP Environment, Guidelines for Brazilian Patent Applications, and Guidelines for Australian Patent Applications, contributing significantly to the internationalization of intellectual property standards. An esteemed speaker on the global stage, Mr. Shen has been invited to share his insights on patent enforcement in China and Chinese patent practice at prestigious international conferences including the Annual BPIP Conference in Tel Aviv, Israel, and Patent School Skolkovo in Moscow, Russia. He actively participates in prominent events such as the INTA annual meeting and BIO convention, further enriching the discourse surrounding intellectual property rights on a global scale.
Education and experience
  • 2005 Graduated from the Materials Science and Engineering program at Beihang University (Beijing University of Aeronautics and Astronautics) with a Bachelor's degree in Engineering.
  • 2008 Graduated from the Information Functional Materials program at Beihang University (Beijing University of Aeronautics and Astronautics) with a Master's degree in Engineering.
  • 2008 Joined Kangxin Partners P.C.
Memberships
Honors and awards
  • 2024 Recognized as IAM Strategy 300 Global Leaders
  • 2024 Recognized as The World’s Leading IP Strategist by IAM Strategy 300
Published articles
  • Changes to utility model and design patent applications - How to navigate preliminary examinations, Managing IP- China IP Focus, Vol. 2014

  • Impact and enlightment from purchase of patents of Rockstar by RPX, China Invention and Patent, Vol. 5, 2015

  • Analysis on thoughts for reply office action regarding insufficient disclosure issue, China Intellectual Property News, Vol. May 11th, 2016

  • Time limit of divisional patent application, Patent Agency, Vol. 1, 2018

  • How to pursue protection for dual use in cosmetic and medical industries, Kangxin official website, Feb 27th, 2020

  • Analysis on strategy of confidentiality examination for international patent applications of Sino-US joint venture, China Intellectual Property News, Vol. Jun 24th, 2020

  • Recent updates for patent term compensation mechanism, Kangxin official website, May 28th, 2021

  • Beijing IP court issues “Reference for case filing in civil cases involving patent dispute related to drugs of which applications for registration are filed (Trail implementation)” and the interpretation of the same, Kangxin official website, Jan 5th, 2022

返回顶部图标